Skip to main content
. 2022 Jan 13;23(2):826. doi: 10.3390/ijms23020826

Figure 5.

Figure 5

Tissue vascularity and oxygenation associated with SBRT or SBRT and immunotherapy. (a) Fold change in density of CD31+ endothelial cells in post-treatment relative to pre-treatment samples for dogs treated with SBRT or SBRT + immunotherapy (SBRT n = 6, SBRT and immunotherapy n = 5); (b) fold change in tumor hemoglobin saturation post-treatment relative to pre-treatment. (SBRT n = 3, SBRT and immunotherapy n = 2).